To Evaluate the Efficacy of Afatinib in the Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer With NRG1 Fusion
Clinical trial NCT04814056 · UNKNOWN
Trial details
- NCT number
- NCT04814056
- Sponsor
- Shanghai Chest Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-01
- Primary completion
- 2023-09-29
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.